Search

everythinglearnresearchcommunity

for

Search:↓

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Melanoma survival rates vary by state and are better where incomes are higher, more people have health insurance and education, and there are more dermatologists.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

Mimicking growth factors in a topical solution can prolong hair growth phase and reduce hair loss without side effects.

A woman's nail separation was likely caused by poor blood flow, and a treatment for similar conditions might help.

Surgery on a baby with a skin disorder improved eyelid position and eye health.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

5% minoxidil works better for hair growth and density, with minor irritation.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Minoxidil, finasteride, and low-level laser light therapy effectively treat hair loss.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.